Valuation : COMPASS Pathways plc

Market Cap 1.99B 1.71B 1.62B 1.47B 2.76B 190B 2.77B 19.25B 7.4B 96.58B 7.46B 7.3B 305B P/E 2026 *
-6.67x
P/E 2027 * -8.56x
Enterprise Value 1.63B 1.4B 1.33B 1.2B 2.26B 156B 2.27B 15.78B 6.07B 79.13B 6.11B 5.98B 250B EV / Sales 2026 *
-
EV / Sales 2027 * 39.2x
Free-Float
-
Yield 2026 *
-
Yield 2027 * -
1 day+0.91%
1 week+8.14%
Current month+6.22%
1 month+7.25%
3 months+25.77%
6 months+108.27%
Current year+107.97%
1 week 13.18
Extreme 13.18
15.87
1 month 12.72
Extreme 12.725
15.87
Current year 4.88
Extreme 4.88
15.87
1 year 4.82
Extreme 4.82
15.87
3 years 2.25
Extreme 2.25
15.87
5 years 2.25
Extreme 2.25
49.52
10 years 2.25
Extreme 2.25
61.69
Manager TitleAgeSince
Chief Executive Officer 61 01/08/2022
Director of Finance/CFO 54 01/03/2024
Chief Tech/Sci/R&D Officer 66 01/05/2024
Director TitleAgeSince
Chairman 74 29/03/2024
Director/Board Member 69 01/04/2020
Director/Board Member 67 01/03/2021
Date Insider Type Main position Quantity % Market Cap. Importance
3/8/26 Tax

Chief Executive Officer

-5,962 0.0062%
27/5/26 Free

Director

21,110 0.0220%
27/5/26 Free

Director

21,110 0.0220%
Change 5-day change 1-year change 3-year change Capi.($)
+0.91%+8.14%+173.85%+57.52% 1.99B
-0.71%-6.35%-4.87%+9.03% 45.48B
+0.21%-2.98%+340.68%+519.93% 43.69B
+1.74%-2.24%+37.28%+21.57% 43.09B
+1.38%-3.28%+3.23%+65.60% 39.4B
-1.44%-5.26%+8.78%+36.85% 31.91B
+0.87%-2.60% - - 17.31B
+0.75%-0.64%+18.07%+110.32% 16.4B
-0.31%-2.78%+10.47%+30.49% 14.24B
+1.93%-3.55%+74.20%+39.37% 13.28B
Average +0.53%-2.40%+73.52%+98.96% 26.68B
Weighted average by Cap. +0.41%-3.58%+73.96%+123.04%

Financials

2026 *2027 *
Net sales - 39.7M 34.2M 32.39M 29.35M 55.07M 3.79B 55.35M 385M 148M 1.93B 149M 146M 6.1B
Net income -299M -257M -244M -221M -414M -28.52B -416M -2.89B -1.11B -14.51B -1.12B -1.1B -45.86B -252M -217M -205M -186M -349M -24.06B -351M -2.44B -939M -12.24B -946M -925M -38.69B
Net Debt -359M -309M -293M -265M -498M -34.3B -501M -3.48B -1.34B -17.45B -1.35B -1.32B -55.14B -432M -372M -353M -320M -600M -41.29B -603M -4.19B -1.61B -21B -1.62B -1.59B -66.37B
Logo COMPASS Pathways plc
Compass Pathways plc is a United Kingdom-based biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The Company is engaged in treating mental health conditions focused on rapid and durable responses through the development of its investigational COMP360 psilocybin treatment. COMP360 is its psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin, optimized for stability and purity. The Company’s initial focus is on treatment-resistant depression (TRD), comprising patients who are inadequately served by the current treatment paradigm. It commenced its Phase III program evaluating its COMP360 psilocybin treatment in TRD. In addition, the Company has ongoing Phase II trials in PTSD and anorexia nervosa. It also provides support to research institutions conducting investigator-initiated studies with COMP360 psilocybin in areas of serious unmet need.
Employees
156
Date Price Change Volume
11/09/26 US$14.35 +0.91% 2,015,599
10/09/26 US$14.22 -6.26% 3,322,692
09/09/26 US$15.17 +8.05% 7,741,965
08/09/26 US$14.04 +5.80% 3,366,302
04/09/26 US$13.27 -0.15% 794,907
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
14.35USD
Average target price
23.75USD
Spread / Average Target
+65.51%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CMPS Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!